featured programs

.
.

"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death..

eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..

but shocking figures uncovered by labour yesterday show some patients are suffering agonising waits of as many as 541 days to begin treatment...cancel.

the mayor said the city is undertaking a massive expansion of homeless services that includes building shelters and adding new restroom facilities.